OSBPL9P3

Across TCGA pan-cancer cohorts, OSBPL9P3 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OSBPL9P3 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OSBPL9P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OSBPL9P3 expression acts as an unfavorable survival marker, although some lineages such as GBM and READ show a favorable association.

BLCA, TGCT, and GBM are the cancer types where OSBPL9P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.271	0.621	<.001	135	view →
TGCT	OS	Tertile	II,III,IV	0.501	0.996	<.001	72	view →
GBM	OS	Tertile	All	0.654	0.309	<.001	21	view →
KIRP	DFS	Tertile	II,III,IV	0.595	0.780	.034	12	view →
READ	DFS	Tertile	All	1.000	0.497	.037	12	view →
SKCM	OS	Tertile	IV	0.226	0.613	.034	9	view →
STAD	OS	Median	IV	0.511	0.176	.005	9	view →
HNSC	DFS	Tertile	All	0.118	0.363	.035	9	view →
ESCA	OS	Quartile	II,III,IV	0.763	0.445	.024	7	view →
LUAD	DFS	Tertile	II,III,IV	1.000	0.696	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OSBPL9P3–BLCA (DFS)

Open the BLCA breakdown →